Issue: April 2017, Posted Date: 4/10/2017
Aptar Pharma Unveils its eDose Counter for MDIs at RDD Europe 2017
Aptar Pharma recently announced it will present its
patented eDose Counter for Metered Dose Inhalers (MDIs), designed to be
easy-to-use and reliable, and contributes to patient compliance, at the RDD Europe 2017 conference in Nice France, April 25-28, 2017.
unique sensing technology offers direct detection of the spray which eliminates
risks of miscounting. The sensing technology is versatile and compatible with
any metering valve design. Our eDose Counter for MDIs includes inhaler priming
and medication reminders-to-use and end-of-product-life warnings (flashing
digits) while remaining cost-effective.
information on Aptar Pharma’s eDose Counter for MDIs, please meet us at our
table top at RDD Europe 2017 conference and/or visit our website:
About Aptar Pharma
is part of the AptarGroup, Inc. family of companies, along with Aptar Beauty + Home
and Aptar Food + Beverage. The company creates innovative drug delivery systems
that meet the evolving needs of biotechnology, healthcare and pharmaceutical companies
around the world.
provides customers with a wide range of delivery technologies and analytical
services backed by decades of proven expertise. AptarGroup is headquartered in
Crystal Lake, Illinois, United States, with manufacturing facilities in North
America, Europe, Asia and South America. For more information, visit www.aptar.com/pharma.
33 1 39 17 20 20
This record has been viewed 212 times.